相似文献
1
Improving outcomes with POCT for HbA1c and blood ketone testing.
J Diabetes Sci Technol. 2007 Jan;1(1):133-6. doi: 10.1177/193229680700100122.
2
Assessment of Patient Satisfaction with On-Site Point-of-Care Hemoglobin A1c Testing: An Observational Study.
Diabetes Ther. 2021 Sep;12(9):2531-2544. doi: 10.1007/s13300-021-01126-7. Epub 2021 Aug 7.
3
The role of point-of-care blood testing for ketones in the diagnosis of diabetic ketoacidosis.
S Afr Med J. 2015 Sep 14;105(9):756-9. doi: 10.7196/SAMJnew.7889.
4
Effects of Point-Of-Care Testing in General Practice for Type 2 Diabetes Patients on Ambulatory Visits and Hospitalizations.
Int J Environ Res Public Health. 2020 Aug 26;17(17):6185. doi: 10.3390/ijerph17176185.
5
Point-of-care testing in diabetes care.
Mini Rev Med Chem. 2011 Feb;11(2):178-84. doi: 10.2174/138955711794519474.
6
Validation and effect on diabetes control of glycated haemoglobin (HbA1c) point-of-care testing.
S Afr Med J. 2019 Jan 31;109(2):112-115. doi: 10.7196/SAMJ.2019.v109i2.13447.
7
Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
Rural Remote Health. 2009 Jul-Sep;9(3):1189. Epub 2009 Aug 10.
8
Quality error rates in point-of-care testing.
Clin Chem. 2011 Sep;57(9):1267-71. doi: 10.1373/clinchem.2011.164517. Epub 2011 Jul 22.
9
Exploring the clinical utility of blood ketone levels in the emergency department assessment of paediatric patients.
Emerg Med J. 2006 Oct;23(10):783-7. doi: 10.1136/emj.2006.035758.
10
Utility of ketone measurement in the prevention, diagnosis and management of diabetic ketoacidosis.
Diabet Med. 2015 Jan;32(1):14-23. doi: 10.1111/dme.12604. Epub 2014 Nov 19.
引用本文的文献
1
Type 1 Diabetes - A Clinical Perspective.
Point Care. 2017 Mar;16(1):37-40. doi: 10.1097/POC.0000000000000125.
本文引用的文献
1
Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial.
Diabet Med. 2006 Mar;23(3):278-84. doi: 10.1111/j.1464-5491.2005.01771.x.
2
Glycated hemoglobin assessment in clinical practice: comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study).
Diabetes Technol Ther. 2005 Dec;7(6):907-12. doi: 10.1089/dia.2005.7.907.
3
Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
Diabetes Care. 2006 Jan;29(1):1-8. doi: 10.2337/diacare.29.01.06.dc05-1058.
4
Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study.
Pediatr Diabetes. 2005 Mar;6(1):13-6. doi: 10.1111/j.1399-543X.2005.00088.x.
5
Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.
Diabetes Care. 1999 Nov;22(11):1785-9. doi: 10.2337/diacare.22.11.1785.
6
Metabolic and clinical significance of ketosis.
Spec Top Endocrinol Metab. 1982;4:1-27.
7
Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus.
N Engl J Med. 1990 Oct 11;323(15):1021-5. doi: 10.1056/NEJM199010113231503.
Zotero 插件